Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1966 1
1967 1
1968 1
1972 2
1973 1
1975 2
1976 2
1977 2
1978 6
1979 11
1980 6
1981 10
1982 9
1983 10
1984 12
1985 8
1986 15
1987 4
1988 11
1989 10
1990 9
1991 14
1992 14
1993 22
1994 17
1995 17
1996 11
1997 13
1998 20
1999 20
2000 17
2001 25
2002 19
2003 24
2004 32
2005 31
2006 29
2007 29
2008 36
2009 46
2010 51
2011 42
2012 57
2013 60
2014 68
2015 63
2016 51
2017 53
2018 75
2019 62
2020 71
2021 94
2022 95
2023 71
2024 89
2025 109
2026 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,535 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP, Goldschmidt CH, Rae-Grant AD. McGinley MP, et al. JAMA. 2021 Feb 23;325(8):765-779. doi: 10.1001/jama.2020.26858. JAMA. 2021. PMID: 33620411 Review.
IMPORTANCE: Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. ...This review summarizes current evidence regarding diagnosis and treat …
IMPORTANCE: Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characte …
Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis.
Lorenzut S, Negro ID, Pauletto G, Verriello L, Spadea L, Salati C, Musa M, Gagliano C, Zeppieri M. Lorenzut S, et al. J Integr Neurosci. 2025 Jan 21;24(1):25081. doi: 10.31083/JIN25081. J Integr Neurosci. 2025. PMID: 39862004 Free article. Review.
The complicated neurological syndrome known as multiple sclerosis (MS) is typified by demyelination, inflammation, and neurodegeneration in the central nervous system (CNS). ...Demyelination interferes with the ability of the CNS to transmit signals, which can cause …
The complicated neurological syndrome known as multiple sclerosis (MS) is typified by demyelination, inflammation, and neurode …
Rehabilitation treatment of multiple sclerosis.
Duan H, Jing Y, Li Y, Lian Y, Li J, Li Z. Duan H, et al. Front Immunol. 2023 Apr 6;14:1168821. doi: 10.3389/fimmu.2023.1168821. eCollection 2023. Front Immunol. 2023. PMID: 37090712 Free PMC article. Review.
Multiple sclerosis is a slowly progressive disease, immunosuppressants and other drugs can delay the progression and progression of the disease, but the most patients will be left with varying degrees of neurological deficit symptoms, such as muscle weakness, …
Multiple sclerosis is a slowly progressive disease, immunosuppressants and other drugs can delay the progression and progressi …
Sensory symptoms of multiple sclerosis may be clues to causation: review and a hypothesis.
Nelson DA. Nelson DA. Del Med J. 1992 Mar;64(3):205-13. Del Med J. 1992. PMID: 1397403 Review.
Sensory signs and symptoms occur in 75 percent of patients with multiple sclerosis (MS), ranking second to coordination defects. ...This review summarizes the sensory signs and symptoms of multiple sclerosis, traces the embr …
Sensory signs and symptoms occur in 75 percent of patients with multiple sclerosis (MS), ranking second to coord …
Multiple Sclerosis.
Schiess N, Calabresi PA. Schiess N, et al. Semin Neurol. 2016 Aug;36(4):350-6. doi: 10.1055/s-0036-1585456. Epub 2016 Sep 19. Semin Neurol. 2016. PMID: 27643903 Free article. Review.
It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Each MS attack can affect function in cognitive, emotional, motoric, sensory, or visual domains. ...
It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Eac …
Multiple sclerosis update.
Markowitz CE. Markowitz CE. Am J Manag Care. 2013 Nov;19(16 Suppl):s294-300. Am J Manag Care. 2013. PMID: 24494618 Free article. Review.
Multiple sclerosis (MS) is a chronic but incurable disease of the central nervous system (CNS) that is often diagnosed in the second or third decade of life. ...There are 4 identified disease courses in MS, and approximately 85% of people with MS present with relaps …
Multiple sclerosis (MS) is a chronic but incurable disease of the central nervous system (CNS) that is often diagnosed in the …
Therapeutics for multiple sclerosis symptoms.
Ben-Zacharia AB. Ben-Zacharia AB. Mt Sinai J Med. 2011 Mar-Apr;78(2):176-91. doi: 10.1002/msj.20245. Mt Sinai J Med. 2011. PMID: 21425263 Review.
Symptoms management in multiple sclerosis is an integral part of its care. Accurate assessment and addressing the different symptoms provides increased quality of life among patients with multiple sclerosis. Multiple sclerosis …
Symptoms management in multiple sclerosis is an integral part of its care. Accurate assessment and addressing the diffe …
Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity.
Rae-Grant AD, Eckert NJ, Bartz S, Reed JF. Rae-Grant AD, et al. Mult Scler. 1999 Jun;5(3):179-83. doi: 10.1177/135245859900500307. Mult Scler. 1999. PMID: 10408718
OBJECTIVE: To assess the frequency and quality of sensory symptoms in a population of patients with Multiple Sclerosis (MS) and compare them with controls. ...There was however a strong correlation between the total number of sensory symptoms …
OBJECTIVE: To assess the frequency and quality of sensory symptoms in a population of patients with Multiple Scleros …
Paediatric-onset multiple sclerosis: demographics, symptoms and disease progression.
Ellenberger D, Flachenecker P, Haas J, Hellwig K, Pöhlau D, Stahmann A, Warnke C, Zettl UK, Rommer PS. Ellenberger D, et al. J Neurol Neurosurg Psychiatry. 2026 Jan 13;97(2):175-182. doi: 10.1136/jnnp-2025-336680. J Neurol Neurosurg Psychiatry. 2026. PMID: 40921616
BACKGROUND: Multiple sclerosis (MS) is the most common neuroimmunological disease in young adults. Data on its clinical onset before the age of 18 (paediatric-onset MS (POMS)) are limited. ...RESULTS: The results showed a diagnostic delay and a higher proportion of …
BACKGROUND: Multiple sclerosis (MS) is the most common neuroimmunological disease in young adults. Data on its clinical onset …
Rare onset symptoms in multiple sclerosis.
Evlice A, Demir T, Kaleağası C, Özcan F, Demirkıran M. Evlice A, et al. Acta Clin Belg. 2016 Jun;71(3):154-7. doi: 10.1080/17843286.2016.1147675. Epub 2016 Apr 21. Acta Clin Belg. 2016. PMID: 27098603
INTRODUCTION: Multiple sclerosis (MS) may present with unusual manifestations such as pain syndromes, movement disorders, rare cranial nerve involvement, cognitive or psychiatric symptoms, leading to diagnostic dilemma. The purpose of this study is to determi …
INTRODUCTION: Multiple sclerosis (MS) may present with unusual manifestations such as pain syndromes, movement disorders, rare …
1,535 results